Laparoscopic-assisted Versus Ultrasonography-guided Transversus Abdominis Plane Block in Laparoscopic Sleeve Gastrectomy

Cairo University1 site in 1 country74 target enrollmentApril 1, 2024

ConditionsTransversus Abdominis Plane

Overview

Phase: N/A
Intervention: Not specified
Conditions: Transversus Abdominis Plane
Sponsor: Cairo University
Enrollment: 74
Locations: 1
Primary Endpoint: morphine needed
Status: Enrolling by Invitation
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The transversus abdominis plane (TAP) block, whereby local anesthetic is injected between the internal oblique and transversus abdominis fascia to facilitate blockade of somatic afferents nerves, is an effective, non-narcotic adjunct incorporated into many ERAS protocols. We hypothesized that surgeon delivered LAP-TAPs would be non-inferior to anesthesia-delivered US-TAPs in terms of post-operative pain control

Registry

clinicaltrials.gov

Start Date

April 1, 2024

End Date

May 1, 2025

Last Updated

2 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Cairo University

Responsible Party

Principal Investigator

Amr Samir Wahdan

Assistant Professor

Cairo University

Eligibility Criteria

Inclusion Criteria

•Elective laparoscopic sleeve gastrectomy aging \> 18years BMI \> 40 kg/m2, ASA score I-III

Exclusion Criteria

•history of chronic opioid consumption suffering from contraindications to regional blocks suffering from allergy to study drugs, history of prior complex abdominal wall reconstruction